Latham & Watkins LLP represented Immuneering Corporation in the transaction. Immuneering Corporation has announced the completion of an oversubscribed US$62 million Series B financing led by…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
